Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
timolol adrenergic receptor beta-1 NA Successful target TTD , DGIDB Hypertensive disease[MeSHID:D006973]
Glaucoma
Open-Angle[MeSHID:D005902]
Ocular Hypertension[MeSHID:D009798]
Physiologic Intraocular Pressure[MeSHID:D007429]
Eye[MeSHID:D005123]
Migraine Disorders[MeSHID:D008881]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 3 approved unknown
timolol adrenergic receptor beta-1 NA Successful target TTD , DGIDB Hypertensive disease[MeSHID:D006973]
Glaucoma
Open-Angle[MeSHID:D005902]
Ocular Hypertension[MeSHID:D009798]
Physiologic Intraocular Pressure[MeSHID:D007429]
Eye[MeSHID:D005123]
Migraine Disorders[MeSHID:D008881]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 3 approved antagonist
timolol beta-1 adrenergic receptor small molecule NA drugbank , DGIDB Hypertensive disease[MeSHID:D006973]
Glaucoma
Open-Angle[MeSHID:D005902]
Ocular Hypertension[MeSHID:D009798]
Physiologic Intraocular Pressure[MeSHID:D007429]
Eye[MeSHID:D005123]
Migraine Disorders[MeSHID:D008881]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 3 approved antagonist
timolol beta-2 adrenergic receptor small molecule NA drugbank , DGIDB Hypertensive disease[MeSHID:D006973]
Glaucoma
Open-Angle[MeSHID:D005902]
Ocular Hypertension[MeSHID:D009798]
Physiologic Intraocular Pressure[MeSHID:D007429]
Eye[MeSHID:D005123]
Migraine Disorders[MeSHID:D008881]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.69 approved antagonist
click here to return to the previous page